Allkem shares fall as investors digest poor quarter at Mt Cattlin Wet weather hammers Yancoal production but record thermal prices ... Read More The post...
The article A Deeper Look at Ketamine and its Potential for Addiction was originally published on Microdose. Ketamine might be the current poster child...
Silo Pharma (NASDAQ: SILO) shares are catching a bid, moving 16% higher to reach $6.39 on Tuesday. The move isn’t surprising; SILO is attracting the...
MindMed ($MNMD) – the starry-eyed prospect in the psychedelic biotech space has recently turned into a soap opera starring Freeman Capital, angry retail...
The conference begins Oct. 13 in NYC. The post 5 Things To Not Miss At Horizons Psychedelics Conference appeared first on Green Market Report.
A separation of Sandoz via a 100 percent spin-off will create the leading European generics company and a global leader in biosimilars, and a more focused...
Hello, friends, and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package. Daily Crunch:...
A new generation of patients can be powerful motivators for a pharmaceutical industry historically resistant to change. And if they don’t respect or...
Source: Dr. Elemer Piros 10/06/2022 Read to learn why ROTH Capital Partners gave Atai Life Sciences NV a Buy rating and a target price 10...
The acquisition is the latest sign of stress among startups in the sector, which has seen valuations plummet. The post Eleusis Holdings Plans To Be Acquired...